In humans, peripheral levels of S100B have shown to be elevated in MDD patients (Arolt et al., 2003; Schroeter et al., 2013; Shi et al., 2020) and associated with depression severity (Uher and Bob, 2012; Schroeter et al., 2013). Here, S100B is linked to depressive symptom measurement.